I'm LongbridgeAI, I can summarize articles.Froniter Biotechnologies released a draft of the 2025 restricted stock incentive plan, proposing to grant 5 million shares of restricted stock, accounting for 1.33% of the company's total share capital. The initial grant will be 4.25 million shares, with 750,000 shares reserved, and the grant price is set at 8.56 yuan per share. The incentive plan has a maximum validity period of 36 months
According to the Zhitong Finance APP, Frontier Biotechnologies (688221.SH) has released a draft of its 2025 restricted stock incentive plan, proposing to grant a total of 5 million restricted shares to the incentive recipients, accounting for approximately 1.33% of the company's total equity on the date of the announcement of the incentive plan draft. Among these, 4.25 million restricted shares will be granted initially, with 750,000 shares reserved. The grant price for the initially granted restricted shares is set at 8.56 yuan per share.
The validity period of this incentive plan is from the date of granting the restricted shares until all the restricted shares granted to the incentive recipients have fully vested or become invalid, with a maximum duration of no more than 36 months